v3.26.1
Condensed Consolidated Statements of Cash Flows - EUR (€)
€ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Statement of cash flows [abstract]    
CASH FLOWS FROM OPERATING ACTIVITIES € (19,259) € 2,604
Profit/(loss) for the period 9,414 7,463
Adjustments made to obtain the cash flows from operating activities 12,668 17,400
Depreciation and amortisation cost 1,667 1,626
Other adjustments 11,001 15,774
Net increase/(decrease) in operating assets 101,714 33,806
Financial assets held-for-trading 29,050 9,104
Non-trading financial assets mandatorily at fair value through profit or loss 87 (398)
Financial assets at fair value through profit or loss (178) 882
Financial assets at fair value through other comprehensive income (2,416) (6,706)
Financial assets at amortised cost 72,690 29,804
Other operating assets 2,481 1,120
Net increase/(decrease) in operating liabilities 62,773 12,664
Financial liabilities held-for-trading 18,718 5,777
Financial liabilities designated at fair value through profit or loss 1,029 (817)
Financial liabilities at amortised cost 45,633 7,039
Other operating liabilities (2,607) 665
Income tax recovered/(paid) (2,400) (1,117)
CASH FLOWS FROM INVESTING ACTIVITIES 6,273 (563)
Payments 9,621 4,247
Tangible assets 2,844 3,202
Intangible assets 684 812
Investments 260 46
Subsidiaries and other business units 3,318 187
Non-current assets held for sale and associated liabilities 2,515 0
Other payments related to investing activities 0 0
Proceeds 15,894 3,684
Tangible assets 2,935 2,927
Intangible assets 0 0
Investments 175 275
Subsidiaries and other business units 5,270 53
Non-current assets held for sale and associated liabilities 7,514 429
Other proceeds related to investing activities 0 0
CASH FLOWS FROM FINANCING ACTIVITIES (5,757) (8,058)
Payments 9,500 8,936
Dividends 1,800 1,643
Subordinated liabilities 2,345 4,084
Redemption of own equity instruments 0 0
Acquisition of own equity instruments 4,640 2,021
Other payments related to financing activities 715 1,188
Proceeds 3,743 878
Subordinated liabilities 2,682 306
Issuance of own equity instruments 0 0
Disposal of own equity instruments 944 542
Other proceeds related to financing activities 117 30
EFFECT OF FOREIGN EXCHANGE RATE DIFFERENCES 1,955 (8,185)
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS (16,788) (14,202)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 154,796 192,208
CASH AND CASH EQUIVALENTS AT END OF PERIOD 138,008 178,006
COMPONENTS OF CASH AND CASH EQUIVALENTS AT END OF PERIOD    
Cash 6,579 6,807
Cash equivalents at central banks 119,102 158,978
Other financial assets 12,327 9,770
Less: Bank overdrafts refundable on demand 0 0
TOTAL CASH AND CASH EQUIVALENTS AT END OF PERIOD 138,008 175,555
In which: restricted cash 0 0
TOTAL CASH AND CASH EQUIVALENTS AT END OF PERIOD ASSOCIATED WITH NON-CURRENT ASSETS HELD FOR SALE € 0 € 2,451